CELG-RI

Bristol-Myers Squibb Company CeNYSEHealthcare

$0.12+34.76%OpenMarket Cap: $243.2M

As of 2026-04-06

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$12.50B	66.2%	$3.63B	$1.09B	$0.53	—
FY 2025	$48.19B	72.5%	$15.12B	$7.05B	$3.46	—
Q3 2025	$12.22B	66.0%	$3.85B	$2.20B	$1.08	—
Q2 2025	$12.27B	65.8%	$4.12B	$1.31B	$0.64	—
Q1 2025	$11.20B	65.5%	$3.52B	$2.46B	$1.20	—
Q4 2024	$12.34B	60.2%	$2.53B	$72.0M	$0.04	—
FY 2024	$48.30B	56.8%	$9.66B	$-8.95B	$-4.41	$0.02
Q3 2024	$11.89B	55.6%	$2.29B	$1.21B	$0.60	—
Q2 2024	$12.20B	73.2%	$1.69B	$1.68B	$0.83	—
Q1 2024	$11.87B	75.3%	$1.51B	$-11.91B	$-5.89	$0.02
Q4 2023	$11.48B	76.1%	$1.90B	$1.76B	$0.87	—
FY 2023	$45.01B	76.2%	$8.20B	$8.03B	$3.86	—